Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 5NIH 2NETWORK 2OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Esophageal Neoplasms 3Breast Neoplasms 3Recurrence 2Fallopian Tube Neoplasms 2Uterine Cervical Neoplasms 1Unresectable Non-small Cell Lung Cancer 1Thyroid Neoplasms 1Stomach Neoplasms 1Sexual Dysfunction, Physiological 1Radiation Injuries 1Prostatic Neoplasms 1Pilonidal Sinus 1Pain, Postoperative 1Pain 1Ovarian Neoplasms 1Neoplasm Metastasis 1Mouth Neoplasms 1Melanoma 1Lung Neoplasms 1Intestinal Diseases 1Head and Neck Neoplasms 1Endometrial Neoplasms 1Death 1Colonic Neoplasms 1Carcinoma, Ovarian Epithelial 1Carcinoma, Hepatocellular 1Adenocarcinoma 1

Interventions

Hyperthermic Intraperitoneal Chemotherapy 2pembrolizumab 1lenvatinib 1fluzoparib 1apatinib 1Surgical Procedures, Operative 1Quality of Life 1Paclitaxel 1Nutritional Status 1Neoadjuvant Therapy 1Interviews as Topic 1Indocyanine Green 1Drug Therapy 1Diagnostic Imaging 1Cisplatin 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER_GOV × Carcinoma, Ovarian Epithelial × Surgical Procedures, Operative × Clear all
NCT06602063 2025-06-27

Surgery for Relapsed Ovarian Cancer in Precision

Shanghai Gynecologic Oncology Group

Phase 1/2 Not yet recruiting
33 enrolled
Gynecologic

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡